7:02 AM
 | 
Aug 14, 2018
 |  BC Extra  |  Company News

Juvenescence, partners form anti-aging biotech

Juvenescence Ltd. (Douglas, Isle of Man), Insilico Medicine Inc. (Baltimore, Md.) and the Buck Institute for Research on Aging (Novato, Calif.) partnered to form anti-aging company Napa Therapeutics Ltd. (Tortola, British Virgin Islands).

Napa will use Insilico's deep learning platform to discover small molecules against an undisclosed aging-related target in collaboration with Buck Institute President and CEO Eric Verdin's lab.

The newco is...

Read the full 293 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >